首页|Tianjin First Central Hospital Reports Findings in Bladder Cancer (Robot-assiste d, laparoscopic and open radical cystectomy for bladder cancer: A sys-tematic re view and network meta-analysis)
Tianjin First Central Hospital Reports Findings in Bladder Cancer (Robot-assiste d, laparoscopic and open radical cystectomy for bladder cancer: A sys-tematic re view and network meta-analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology-Bladder Can cer is the subject of a report. According to news reporting originating from Tia njin, People's Republic of China, by NewsRx correspondents, research stated, "To evaluate the safety and effectiveness of robot-assisted radical cystectomy (RAR C), laparoscopic radical cystectomy (LRC), and open radical cystectomy (ORC) in bladder cancer. A literature search for network meta-analysis was conducted usin g international databases up to February 29, 2024." Our news editors obtained a quote from the research from Tianjin First Central H ospital, "Outcomes of interest included baseline characteristics, perioperative outcomes and oncological outcomes. Forty articles were finally selected for incl usion in the network meta-analysis. Both LRC and RARC were associated with longe r operative time, smaller amount of estimated blood loss, lower transfusion rate , shorter time to regular diet, fewer incidences of complications, and fewer pos itive surgical margin compared to ORC. LRC had a shorter time to flatus than ORC , while no difference between RARC and ORC was observed. Considering lymph node yield, there were no differences among LRC, RARC and ORC. In addition, there wer e statistically significant lower transfusion rates (OR=-0.15, 95% CI=-0.47 to 0.17), fewer overall complication rates (OR=-0.39, 95% CI=-0.79 to 0.00), fewer minor complication rates (OR=-0.23, 95% C I=-0.48 to 0.02), fewer major complication rates (OR=-0.23, 95% CI =-0.68 to 0.21), fewer positive surgical margin rates (OR=0.22, 95% CI=-0.27 to 0.68) in RARC group compared with LRC group. LRC and RARC could be c onsidered as a feasible and safe alternative to ORC for bladder cancer. Notably, compared with LRC, RARC may benefit from significantly lower transfusion rates, fewer complications and lower positive surgical margin rates."
TianjinPeople's Republic of ChinaAsi aBladder CancerBlood TransfusionCancerCystectomyEmerging TechnologiesHealth and MedicineMachine LearningMedical DevicesOncologyRadical Cyste ctomyRobotRoboticsSurgeryTransfusion MedicineUrologic Surgical Procedu res
NETL
NSTL
